Joyce Hollman

Worried about Alzheimer’s, cholesterol and blood pressure? There’s a tea for that

Drinking tea warms the soul. I find it one of the most soothing things I do for myself. What’s even better? Knowing this guilty pleasure has lots of researched benefits—many among the biggest health issues we face today.

Joyce Hollman

The ‘causal link’ to Alzheimer’s you can cut

Research relies on different types of studies. Some are “observational,” where researchers observe the effect of a risk factor. Then there are the ones we get really excited about. These identify an actual causal factor that, if avoided, can greatly cut your risk of something like Alzheimer’s…

Joyce Hollman

Old diabetes drug with a dangerous past may treat Alzheimer’s

Ever hear the expression, “out of the frying pan, into the fire”? It means going from a bad situation to one that may be even worse. Like taking a drug linked to heart issues, bladder cancer and liver toxicity and giving it new life as an Alzheimer’s treatment.

Dr. Adria Schmedthorst

Why a hospital stay could increase risk for Alzheimer’s and Parkinson’s

No one plans to get sick enough from a viral or bacterial infection to be hospitalized. But now there’s all the more reason to plan to avoid that scenario. That’s because landing in the hospital for infection just a couple of times could greatly impact the health of your brain a few years later…

Dr. Adria Schmedthorst

More COVID fallout: More than double the Alzheimer’s risk

Because there’s no cure for Alzheimer’s, our only option to turn the tide is by reducing general risk factors. Working on lifestyle is manageable. But when a pandemic-related virus turns out to up the ante, the task may seem insurmountable, until you know the real trigger…

Carolyn Gretton

The antibody that could take down Alzheimer’s plaques

Alzheimer’s disease therapies leave a lot to be desired. But researchers are learning more about the mechanisms behind the disease and may have found a link to a whole new avenue of treatment… delivering antibody-based therapies across the blood-brain barrier.